Bioton SA (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats.
The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights Bioton SA (Bioton) manufactures medicines and pharmaceutical preparations and produces pharmaceutical substances.Its product portfolio includes antibiotics; anesthetic drugs and eye drops; recombinant human insulin in different forms; human growth hormone and orally taken anti-diabetic medicines.
The company’s also provides strips for measurement of blood sugar and over-the-counter (OTC) preparations including diet supplements, products for particular nutritional uses and cosmetics for patients with certain health problems such as metabolic syndrome and diabetes.Bioton undertakes research activities in the areas of genetic engineering, biotechnology, and pharmacology and offers in-licensing services.
The company operates in Europe, Asia and Australia. Bioton is headquartered in Ozarow Mazowiecki, Masovian, Poland.
Bioton SA Key Recent Developments Feb 14,2017: Scigen says Ashley Morris also joins board as an exec director
Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
The global premature ejaculation therapeutics market is estimated to reach revenues of approximately $3 billion by 2024, growing at a CAGR of around 9% during 2018-2024. The entry of new vendors is leading to high capital investment for R&D activities and manufacturing of new prescription drugs in the global market. The increasing awareness...
201 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Jan 2019
Cell lines are one the major tools used in research for studying the normal physiology and biochemistry of cells, the effects of drugs and toxic compounds on the cells, drug screening and development and large scale manufacturing of biological compounds. Cell culture is the process by which cells are grown under controlled...
2018 Future of Global Medical Nutrition Market To 2025- Growth Opportunities, Competition And Outlook Of Medical Nutrition by Disease Type, Age Group and Flavor Type Across Regions Report Global Medical Nutrition markets are witnessing robust growth due to ongoing drive towards investments and plans for market expansion...
119 pages •
By Infiniti Research Limited
• Jan 2019
About this market Growing demand for sustainable packaging to drive market growth. The growing environmental concerns are increasing the demand for sustainable packaging solutions among the pharmaceutical manufacturers. Plastic films and plastic materials are mostly derived from petroleum feedstock. Their adverse effects...
Chronic Bronchitis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Chronic Bronchitis Global Clinical Trials Review, H2, 2018" provides an overview of Chronic Bronchitis clinical trials scenario.This report provides top line data relating to the clinical trials...
Cerebellar Ataxia Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cerebellar Ataxia Global Clinical Trials Review, H2, 2018" provides an overview of Cerebellar Ataxia clinical trials scenario.This report provides top line data relating to the clinical trials on...
Cholecystitis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cholecystitis Global Clinical Trials Review, H2, 2018" provides an overview of Cholecystitis clinical trials scenario.This report provides top line data relating to the clinical trials on Cholecystitis. Report...
Celiac Disease Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Celiac Disease Global Clinical Trials Review, H2, 2018" provides an overview of Celiac Disease clinical trials scenario.This report provides top line data relating to the clinical trials on Celiac...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.